Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
45.00    2.50 (5.88%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £86.34m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Operational Update

7 Mar 2013 07:00

RNS Number : 4293Z
Iofina PLC
07 March 2013
 



 

 

7 March 2013

 

 

Iofina plc

("Iofina" or the "Group")

(LSE AIM: IOF)

 

Operations Update

 

Iofina, a specialist in the exploration and production of iodine and specialty chemical iodine derivatives, is pleased to announce to shareholders today an Operations Update.

 

 

HIGHLIGHTS:

 

·; IOsorb™ iodine production process proving successful, with 80-95% recovery of iodine contained in iodine rich brine streams;

·; Production at IO#2 plant is in line with expectations and further optimisation is planned;

·; Delivery of IO#3 expected into the US by the end of March;

·; IO#1 and IO#2 are expected to be producing cumulatively over 300 metric tonnes per year

·; Updates on Iofina Chemical and the Atlantis Water Project will be contained in the upcoming year-end trading report

 

WET® IOsorb™ IO#1 ("IO#1") and IO#2 ("IO#2") plants, which are located within the Group's Southwest Operations Group, started production late in the third quarter 2012 and early first quarter 2013 respectively. These initial two plants have already proved that the Group's proprietary iodine production model is a successful process with iodine yield efficiency in the range of 80-95 per cent, with ultimate recovery dependent on brine temperature and iodine part per million contained in each specific brine stream.

 

As previously announced in December 2012, IO#1 was initially limited by both a shortfall of brine, owing to trucking and disposal sites, and issues as to iodine content within the brine. The major independent oil and gas operator has subsequently increased the current average daily brine volume along with iodine content to this location. Iofina created a robust sampling program of the individual wells which translates into a geologic model for the area. Some wells in the area contained marginal iodine content and others are circa 200ppm. The Group now has a better understanding of the well completion techniques that cause this variance and will incorporate this knowledge into its business development strategy for the Company going forward on new sites. Further optimisation of the brine volume and iodine contained in the brine will continue at IO#1 with the goal of obtaining maximum capacity while increasing the overall iodine contained in the brine along with warmer temperatures.

 

IO#2, which, in contrast to IO#1, receives its brine input directly from the producing wells, enjoys far greater certainty as to iodine concentration and higher brine temperatures, which are greater than 40 degrees Celsius. The optimal water temperature helps yield improved efficiency for volume throughput which is now averaging in the low 90 per cent range on extraction efficiency. Initial throughput has been in line with expectations and will continue to increase over the next few weeks. Further wells will be tied in on a regular basis when wells are drilled and completed. IO#2 is performing in line with expectations and further fine tuning will continue to take place over the next 90 days in order to incorporate all the operational improvements learned from IO#1. As things currently stand we expect IO#1 and IO#2 to be producing circa 300 metric tonnes per year cumulatively.

 

As a result of the experience gained from IO#1 and IO#2 to date, the Company is implementing new design improvements, which lend to more efficient construction and plant commissioning, are currently being updated and incorporated. The Group has expanded the in house engineering design team to include drafting, electrical design and programmable logic controller programing and site project management. The Group remains focused on bringing its WET® IOsorb™ IO#3, IO#4, IO#5 and IO#6 plants into production. The delivery of the Group's WET® IOsorb™ IO#3 plant ("IO#3") is expected by the end of March 2013. The final construction of IO#3 is being carefully planned to target the most optimal brine streams available which will lead to higher overall production of iodine in 2013 and beyond.

 

 

Commenting on the update, Lance Baller, CEO and President, stated:

"We are excited about our WET®IOsorb ™ and the opportunity they afford to the Group. Iofina remains focused on becoming a world leader in the production of Iodine and Iodine derivatives and the Board looks forward to what it anticipates to be a fourth consecutive year of record revenues in 2013."

 

For further information, please contact:

 

Lance Baller, CEO

Iofina plc

Tel: +44(0)20 3006 3135

 www.iofina.com

 

Ben Colegrave/Chris Sim/Neil Elliot

Investec

Tel: +44(0)20 7597 5970

 

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739 

 

 

 

About Iofina

Iofina specialises in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, California, Montana, Oklahoma and Wyoming. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilises its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUGUMUWUPWGBQ
Date   Source Headline
14th May 20197:00 amRNSStatement regarding share price rise
1st May 20197:00 amRNSFinal Results
17th Apr 20197:00 amRNSQ1 2019 Market Update
1st Apr 20197:00 amRNSCompletion of Debt Restructuring
22nd Feb 20194:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20194:35 pmRNSPrice Monitoring Extension
12th Feb 20197:00 amRNSDebt Restructuring
1st Feb 20194:40 pmRNSSecond Price Monitoring Extn
1st Feb 20194:35 pmRNSPrice Monitoring Extension
22nd Jan 20197:00 amRNSChange of Registered Office
17th Jan 20197:00 amRNSMarket Update
20th Nov 20184:40 pmRNSSecond Price Monitoring Extn
20th Nov 20184:35 pmRNSPrice Monitoring Extension
16th Nov 20187:00 amRNSDirector Appointment
18th Oct 20184:40 pmRNSSecond Price Monitoring Extn
18th Oct 20184:35 pmRNSPrice Monitoring Extension
10th Oct 20187:00 amRNSQ3 2018 Update
20th Sep 20187:00 amRNSInterim Results
16th Jul 20187:00 amRNSH1 2018 Update
18th Jun 20187:00 amRNSMarket update
14th Jun 20187:00 amRNSGrant of Options
13th Jun 201811:30 amRNSResult of AGM
30th Apr 20187:00 amRNSFinal Results and Notice of AGM
18th Apr 20187:00 amRNSQ1 2018 Market Update
16th Apr 20181:30 pmRNSHolding(s) in Company
11th Apr 20186:20 pmRNSHolding(s) in Company
11th Apr 20186:20 pmRNSHolding(s) in Company
20th Mar 20183:05 pmRNSHolding(s) in Company
15th Mar 20181:24 pmRNSHolding(s) in Company
14th Feb 20187:00 amRNSProduction commences at IO#7
30th Jan 20183:00 pmRNSHolding(s) in Company
15th Jan 20187:00 amRNSMarket Update
14th Dec 20177:00 amRNSMarket Update
16th Nov 20177:00 amRNSIO#7 Progress and Market Update
20th Oct 20174:40 pmRNSSecond Price Monitoring Extn
20th Oct 20174:35 pmRNSPrice Monitoring Extension
10th Oct 20177:00 amRNSQ3 2017 Market Update
22nd Sep 20177:00 amRNSInterim Results
12th Sep 20177:00 amRNSConstruction of IO#7 to Expand Iodine Production
14th Jul 20177:00 amRNSCorporate and Production Update
14th Jun 201712:15 pmRNSResult of AGM
13th Jun 201712:07 pmRNSSecond Price Monitoring Extn
13th Jun 201712:02 pmRNSPrice Monitoring Extension
8th Jun 201712:07 pmRNSSecond Price Monitoring Extn
8th Jun 201712:02 pmRNSPrice Monitoring Extension
7th Jun 201712:07 pmRNSSecond Price Monitoring Extn
7th Jun 201712:02 pmRNSPrice Monitoring Extension
6th Jun 201712:07 pmRNSSecond Price Monitoring Extn
6th Jun 201712:02 pmRNSPrice Monitoring Extension
24th May 20174:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.